Rtw Investments as of Sept. 30, 2021
Portfolio Holdings for Rtw Investments
Rtw Investments holds 120 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 7.1 | $470M | 16M | 29.72 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 5.7 | $375M | 873k | 429.14 | |
| Alnylam Pharmaceuticals (ALNY) | 4.8 | $318M | 1.7M | 188.81 | |
| Mirati Therapeutics | 4.0 | $264M | 1.5M | 176.91 | |
| Thermo Fisher Scientific (TMO) | 3.6 | $238M | 416k | 571.33 | |
| Masimo Corporation (MASI) | 3.4 | $225M | 833k | 270.71 | |
| Vericel (VCEL) | 3.3 | $221M | 4.5M | 48.80 | |
| Celldex Therapeutics Com New (CLDX) | 3.2 | $211M | 3.9M | 53.99 | |
| Natera (NTRA) | 3.1 | $208M | 1.9M | 111.44 | |
| Ptc Therapeutics I (PTCT) | 3.0 | $197M | 5.3M | 37.21 | |
| Illumina (ILMN) | 3.0 | $196M | 483k | 405.61 | |
| Establishment Labs Holdings Ord (ESTA) | 2.5 | $166M | 2.3M | 71.58 | |
| Dicerna Pharmaceuticals | 2.3 | $153M | 7.6M | 20.16 | |
| Tandem Diabetes Care Com New (TNDM) | 2.1 | $139M | 1.2M | 119.38 | |
| Globus Med Cl A (GMED) | 1.9 | $128M | 1.7M | 76.62 | |
| Axonics Modulation Technolog (AXNX) | 1.9 | $127M | 1.9M | 65.09 | |
| Avidity Biosciences Ord (RNA) | 1.8 | $118M | 4.8M | 24.63 | |
| Guardant Health (GH) | 1.7 | $116M | 925k | 125.01 | |
| C4 Therapeutics Com Stk (CCCC) | 1.7 | $112M | 2.5M | 44.68 | |
| Iveric Bio | 1.6 | $109M | 6.7M | 16.24 | |
| Fulcrum Therapeutics (FULC) | 1.6 | $109M | 3.9M | 28.21 | |
| 10x Genomics Cl A Com (TXG) | 1.6 | $107M | 735k | 145.58 | |
| Penumbra (PEN) | 1.5 | $103M | 385k | 266.50 | |
| Dermtech Ord ord (DMTKQ) | 1.5 | $100M | 3.1M | 32.11 | |
| Stoke Therapeutics (STOK) | 1.4 | $93M | 3.6M | 25.44 | |
| Ideaya Biosciences (IDYA) | 1.3 | $83M | 3.3M | 25.49 | |
| Macrogenics (MGNX) | 1.3 | $83M | 4.0M | 20.94 | |
| Prometheus Biosciences | 1.2 | $77M | 3.3M | 23.71 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $77M | 1.8M | 41.92 | |
| Cytokinetics Com New (CYTK) | 1.1 | $72M | 2.0M | 35.74 | |
| Iteos Therapeutics | 1.0 | $64M | 2.4M | 27.00 | |
| Landos Biopharma | 0.9 | $62M | 4.3M | 14.60 | |
| Cutera | 0.9 | $59M | 1.3M | 46.60 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.8 | $56M | 5.7M | 9.80 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.8 | $54M | 6.4M | 8.37 | |
| Axsome Therapeutics (AXSM) | 0.8 | $53M | 1.6M | 32.96 | |
| Tenaya Therapeutics (TNYA) | 0.7 | $49M | 2.5M | 19.76 | |
| Agenus Com New | 0.7 | $48M | 9.1M | 5.25 | |
| Apyx Medical Corporation (APYX) | 0.7 | $47M | 3.4M | 13.85 | |
| Immunocore Hldgs Ads (IMCR) | 0.7 | $46M | 1.2M | 37.07 | |
| Gh Research Ordinary Shares (GHRS) | 0.7 | $46M | 2.2M | 21.08 | |
| Outset Med | 0.7 | $44M | 895k | 49.44 | |
| Tarsus Pharmaceuticals (TARS) | 0.7 | $43M | 2.0M | 21.55 | |
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $42M | 140k | 302.00 | |
| Pulmonx Corp (LUNG) | 0.6 | $42M | 1.2M | 35.98 | |
| Relmada Therapeutics (RLMD) | 0.6 | $40M | 1.5M | 26.21 | |
| Castle Biosciences (CSTL) | 0.6 | $40M | 599k | 66.50 | |
| Nanostring Technologies (NSTGQ) | 0.6 | $39M | 804k | 48.01 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.5 | $32M | 1.3M | 24.25 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $31M | 1.8M | 17.72 | |
| Bellus Health Com New | 0.5 | $30M | 5.0M | 6.13 | |
| Sight Sciences (SGHT) | 0.4 | $29M | 1.3M | 22.70 | |
| Johnson & Johnson (JNJ) | 0.4 | $28M | 171k | 161.50 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $26M | 1.2M | 21.41 | |
| Clearside Biomedical (CLSD) | 0.4 | $25M | 4.2M | 6.00 | |
| Milestone Pharmaceuticals (MIST) | 0.4 | $25M | 4.3M | 5.71 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $24M | 810k | 29.80 | |
| Genetron Hldgs Ads | 0.3 | $23M | 1.7M | 13.85 | |
| Oyster Point Pharma | 0.3 | $22M | 1.9M | 11.85 | |
| Aadi Bioscience (WHWK) | 0.3 | $21M | 765k | 27.90 | |
| Essa Pharma Com New (EPIX) | 0.3 | $21M | 2.6M | 8.00 | |
| Arbutus Biopharma (ABUS) | 0.3 | $20M | 4.7M | 4.29 | |
| Inmode SHS (INMD) | 0.3 | $20M | 125k | 159.45 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.3 | $20M | 667k | 29.50 | |
| Renovacor | 0.3 | $19M | 2.2M | 8.80 | |
| Tela Bio (TELA) | 0.3 | $19M | 1.4M | 13.66 | |
| Athira Pharma (ATHA) | 0.3 | $18M | 1.9M | 9.38 | |
| Adverum Biotechnologies | 0.2 | $16M | 7.5M | 2.17 | |
| Neogenomics Com New (NEO) | 0.2 | $15M | 311k | 47.81 | |
| Urogen Pharma (URGN) | 0.2 | $14M | 858k | 16.82 | |
| OraSure Technologies (OSUR) | 0.2 | $13M | 1.2M | 11.31 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $13M | 1.6M | 8.06 | |
| Immunic (IMUX) | 0.2 | $12M | 1.4M | 8.85 | |
| Vincerx Pharma Com New | 0.2 | $12M | 750k | 16.17 | |
| Exagen (XGN) | 0.2 | $11M | 821k | 13.60 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.2 | $11M | 450k | 24.23 | |
| Jounce Therapeutics | 0.2 | $10M | 1.4M | 7.43 | |
| Nyxoah S A SHS (NYXH) | 0.2 | $10M | 345k | 29.25 | |
| Biomea Fusion (BMEA) | 0.1 | $9.9M | 831k | 11.89 | |
| Lifesci Acquisition Ii Corp | 0.1 | $9.6M | 975k | 9.80 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 0.1 | $9.3M | 2.3M | 3.99 | |
| Tango Therapeutics (TNGX) | 0.1 | $7.8M | 600k | 12.93 | |
| Procept Biorobotics Corp (PRCT) | 0.1 | $7.4M | 194k | 38.15 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $7.4M | 750k | 9.85 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $7.1M | 1.4M | 5.09 | |
| Nautilus Biotechnology (NAUT) | 0.1 | $6.6M | 1.1M | 5.99 | |
| Research Alliance Corp Ii Com Cl A | 0.1 | $6.3M | 637k | 9.85 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $6.1M | 613k | 9.96 | |
| Aslan Pharmaceuticals Ads | 0.1 | $5.8M | 3.3M | 1.78 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $5.3M | 162k | 33.02 | |
| Sophia Genetics Sa Ordinary Shares (SOPH) | 0.1 | $5.3M | 300k | 17.53 | |
| Berkeley Lts | 0.1 | $5.0M | 258k | 19.56 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.0M | 500k | 10.05 | |
| Summit Healthcre Acquistn Unit 06/03/2026 | 0.1 | $5.0M | 500k | 10.05 | |
| Avita Therapeutics (RCEL) | 0.1 | $5.0M | 280k | 17.72 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs | 0.1 | $4.9M | 500k | 9.88 | |
| Immatics SHS (IMTX) | 0.1 | $4.6M | 350k | 13.00 | |
| Acutus Medical (AFIB) | 0.1 | $4.3M | 492k | 8.84 | |
| Aptevo Therapeutics Com New | 0.1 | $4.3M | 281k | 15.44 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $3.8M | 392k | 9.82 | |
| Point Biopharma Global | 0.1 | $3.8M | 490k | 7.69 | |
| Maxcyte (MXCT) | 0.1 | $3.4M | 275k | 12.21 | |
| Montes Archimedes Acquisitio Com Cl A | 0.0 | $3.2M | 400k | 7.90 | |
| Sema4 Holdings Corp Com Cl A | 0.0 | $2.9M | 400k | 7.34 | |
| Medicus Sciences Acquisition Cl A Shs | 0.0 | $2.9M | 300k | 9.75 | |
| CVRX (CVRX) | 0.0 | $2.5M | 150k | 16.54 | |
| Codex Dna | 0.0 | $2.2M | 200k | 11.13 | |
| Twist Bioscience Corp (TWST) | 0.0 | $2.0M | 19k | 106.97 | |
| Miromatrix Med | 0.0 | $1.9M | 280k | 6.96 | |
| Rxsight (RXST) | 0.0 | $1.9M | 150k | 12.67 | |
| MiMedx (MDXG) | 0.0 | $1.8M | 296k | 6.06 | |
| Profound Med Corp Com New (PROF) | 0.0 | $1.8M | 122k | 14.64 | |
| Bolt Biotherapeutics | 0.0 | $1.6M | 126k | 12.65 | |
| Akoya Biosciences (AKYA) | 0.0 | $1.4M | 100k | 13.96 | |
| 908 Devices (MASS) | 0.0 | $1.3M | 40k | 32.52 | |
| Singular Genomics Systems In | 0.0 | $1.1M | 100k | 11.19 | |
| Zymergen | 0.0 | $922k | 70k | 13.17 | |
| Burning Rock Biotech Sponsored Ads | 0.0 | $536k | 30k | 17.87 | |
| Renovacor *w Exp 99/99/999 | 0.0 | $224k | 350k | 0.64 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $24k | 33k | 0.72 |